| Clinical pharmacokinetics of metformin GG Graham, J Punt, M Arora, RO Day, MP Doogue, J Duong, TJ Furlong, ... Clinical pharmacokinetics 50, 81-98, 2011 | 1392 | 2011 |
| Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysis JF Roos, J Doust, SE Tett, CMJ Kirkpatrick Clinical biochemistry 40 (5-6), 383-391, 2007 | 604 | 2007 |
| Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review N Jokanovic, ECK Tan, MJ Dooley, CM Kirkpatrick, JS Bell Journal of the American Medical Directors Association 16 (6), 535. e1-535. e12, 2015 | 454 | 2015 |
| Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and … JA Roberts, CMJ Kirkpatrick, MS Roberts, TA Robertson, AJ Dalley, ... Journal of antimicrobial chemotherapy 64 (1), 142-150, 2009 | 382 | 2009 |
| Resveratrol does not benefit patients with nonalcoholic fatty liver disease VS Chachay, GA Macdonald, JH Martin, JP Whitehead, ... Clinical Gastroenterology and Hepatology 12 (12), 2092-2103. e6, 2014 | 305 | 2014 |
| Dosing in obesity: a simple solution to a big problem PY Han, SB Duffull, CMJ Kirkpatrick, B Green Clinical Pharmacology & Therapeutics 82 (5), 505-508, 2007 | 289 | 2007 |
| Pharmacist-led medication review in community settings: an overview of systematic reviews N Jokanovic, ECK Tan, S Sudhakaran, CM Kirkpatrick, MJ Dooley, ... Research in Social and Administrative Pharmacy 13 (4), 661-685, 2017 | 260 | 2017 |
| First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis JA Roberts, CMJ Kirkpatrick, MS Roberts, AJ Dalley, J Lipman International journal of antimicrobial agents 35 (2), 156-163, 2010 | 227 | 2010 |
| Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram A Chan, GK Isbister, CMJ Kirkpatrick, SB Dufful QJM: An International Journal of Medicine 100 (10), 609-615, 2007 | 211 | 2007 |
| Resveratrol–pills to replace a healthy diet? VS Chachay, CMJ Kirkpatrick, IJ Hickman, M Ferguson, JB Prins, ... British journal of clinical pharmacology 72 (1), 27-38, 2011 | 173 | 2011 |
| Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients JA Roberts, CMJ Kirkpatrick, J Lipman Journal of Antimicrobial Chemotherapy 66 (2), 227-231, 2011 | 168 | 2011 |
| The therapeutic monitoring of antimicrobial agents EJ Begg, ML Barclay, CMJ Kirkpatrick British Journal of Clinical Pharmacology 52 (S1), 35-43, 2001 | 167 | 2001 |
| The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007 SC McLeay, GA Morrish, CMJ Kirkpatrick, B Green Clinical pharmacokinetics 51, 319-330, 2012 | 164 | 2012 |
| Once daily aminoglycoside therapy: is it less toxic than multiple daily doses and how should it be monitored? ML Barclay, CMJ Kirkpatrick, EJ Begg Clinical pharmacokinetics 36, 89-98, 1999 | 150 | 1999 |
| Clinical medication review in Australia: a systematic review N Jokanovic, ECK Tan, D van den Bosch, CM Kirkpatrick, MJ Dooley, ... Research in Social and Administrative Pharmacy 12 (3), 384-418, 2016 | 147 | 2016 |
| Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function JK Duong, SS Kumar, CM Kirkpatrick, LC Greenup, M Arora, TC Lee, ... Clinical pharmacokinetics 52, 373-384, 2013 | 147 | 2013 |
| Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance? AA Udy, J Lipman, P Jarrett, K Klein, SC Wallis, K Patel, CMJ Kirkpatrick, ... Critical Care 19, 1-9, 2015 | 144 | 2015 |
| Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers J Dowling, GK Isbister, CMJ Kirkpatrick, D Naidoo, A Graudins Therapeutic drug monitoring 30 (4), 490-496, 2008 | 144 | 2008 |
| Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia BA Atcheson, PJ Taylor, CMJ Kirkpatrick, SB Duffull, DW Mudge, ... Therapeutic drug monitoring 26 (3), 284-286, 2004 | 140 | 2004 |
| Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep MT Rademaker, CJ Charles, EA Espiner, S Fisher, CM Frampton, ... Journal of the American College of Cardiology 40 (8), 1495-1505, 2002 | 131 | 2002 |
